Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze AGX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate AGX investment potential.

What is AGX stock price today?

Get real-time AGX stock price, historical data, and price charts on Financhill. Track AGX performance with our advanced analysis tools.

Is AGX a good investment?

Evaluate AGX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy AGX stock?

To buy AGX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of AGX?

View detailed market capitalization data and company valuation metrics for AGX on our comprehensive analysis page.

What is the P/E ratio of AGX?

Use our fundamental analysis tools to view AGX P/E ratio and compare valuation metrics with industry peers.

What are AGX earnings?

View AGX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Argan, Inc. 10K Form

Buy

AGX
Argan, Inc.

Last Price:

$332.98

Seasonality Move:

5.99%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-06-06	10Q	AGX/Argan, Inc. Quarterly
2023-12-06	10Q	AGX/Argan, Inc. Quarterly
2023-09-06	10Q	AGX/Argan, Inc. Quarterly
2023-06-08	10Q	AGX/Argan, Inc. Quarterly
2022-12-07	10Q	AGX/Argan, Inc. Quarterly
2022-09-08	10Q	AGX/Argan, Inc. Quarterly

Receive AGX News And Ratings

See the #1 stock for the next 7 days that we like better than AGX

AGX Financial Statistics

Sales & Book Value

Annual Sales:	$874.2M
Cash Flow:	$171.9M
Price / Cash Flow:	16.63
Annual Sales:	$30.25
Price / Book:	11.01

Profitability

EPS (TTM):	8.48460
Net Income (TTM):	$119.9M
Gross Margin:	$142.5M
Return on Equity:	32.29%
Return on Assets:	13.76%

Argan, Inc. Earnings Forecast

Key Argan, Inc. Financial Ratios

The Gross Profit Margin over the past 37 years for AGX is 16.30%.
The Selling, General & Administrative Expenses for AGX have been equal to 6.04% of Gross Profit Margin.
The Research & Development expenses have been 0.00% of Revenue.
The Interest Expense is 0.00% of Operating Income.
The Net Earning history of AGX is 9.78% of Total Revenues.
Per Share Earnings over the last 37 years have been positive in 20 years.

Argan, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSE
Industry:	Construction & Engineering
Sector:	Industrials
Current Symbol:	AGX
CUSIP:	04010E
Website:	arganinc.com

Debt

Debt-to-Equity Ratio:	0.01
Current Ratio:	1.61
Quick Ratio:	1.51

Price-to-Earnings

Trailing P/E Ratio:	54.18
Forward P/E Ratio:	34.86

AGX Technical Analysis vs Fundamental Analysis

Buy

Argan, Inc. (AGX) is a Buy

Is Argan, Inc. a Buy or a Sell?

Argan, Inc. stock is rated a Buy

The current Argan, Inc. [AGX] share price is $333.23. The Score for AGX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.